GlassScriptPhysician profile
Khalid M Eltawil
NPI 1396724399
$25,931.18
in general payments reported to CMS, 2019-2025
38 companies · $1,249 in 2025
The $1,249 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $535 · 2020: $1,255 · 2021: $36.59 · 2022: $2,173 · 2023: $14K · 2024: $6,445 · 2025: $1,249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $16K · Food and Beverage: $3,871 · Travel and Lodging: $1,710 · Gift: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $16,250.00 |
| Food and Beverage | $3,870.62 |
| Travel and Lodging | $1,710.44 |
| Gift | $101.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $19,517.95 | 2022-2024 | Da Vinci Surgical System, Ion |
| Glaxosmithkline, LLC. | $1,204.90 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Covidien LP | $920.47 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $573.31 | 2019-2025 | Airsupra, Breztri, Fasenra |
| Harmony Biosciences LLC | $529.45 | 2020-2025 | Wakix |
| Inspire Medical Systems, INC. | $479.30 | 2022-2025 | Inspire |
| Abiomed | $304.70 | 2022-2024 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $294.07 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Resmed Corp | $196.79 | 2025 | |
| Merck Sharp & Dohme LLC | $161.83 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $154.87 | 2019-2025 | |
| Galvanize Therapeutics, INC | $135.00 | 2024 | Aliya System |
| Haemonetics Corporation | $133.24 | 2025 | Teg6s Hemostasis System |
| Electromed, INC. | $131.54 | 2023-2025 | Smartvest |
| Siemens Medical Solutions USA, INC. | $128.94 | 2024 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khalid Eltawil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.